My name is Febrina Meutiawati and I am Indonesian. I’m currently pursuing my PhD in Medical Microbiology Department, at the Experimental Virology Group, Theme Infectious diseases and global health.
When you were a kid what did you want to be when you grew up? Can you tell us something about your child years.
Since my mother is a teacher in physics, being a teacher was one of my dreams. Besides that, I remembered that I was more interested in life science subjects rather than social and literature subjects. However, as a kid, I was clueless on what scientists do. I only knew one scientist (sadly, a fictional character), dr. Dana Scully. Thanks to the TV series, I gained my interest to the scientific world.
What was your previous academic training, where did you study and why that study?
I got my Bachelor and Master degree on Chemistry and Biochemistry from Bandung Institute of Technology. I was impressed by the scope of chemistry subject which is basically related to everything; physics, biology, medicine and even sometimes philosophy. Therefore, I chose to study the subject. Over time, my interest was more focus on molecular biology and was broaden to virology because there I can understand the molecular mechanism of disease in general, and viruses in specific. Moreover, cell culture works and plaque assays are quite exciting!
The RIMLS motto is: ‘Today’s molecules for tomorrow’s medicine’. What does this mean for you?
The motto basically represents the general topic of my PhD projects of which focus on discovery of antiviral drugs for mosquito-borne viruses. Our approach is by repurposing the collection of small drug-like compounds for antiviral activity screening to identify ones that inhibit dengue virus. Therefore, for me personally, this means every data matters, no experiment goes in vain. Our today’s pointless results may become very useful someday.
Who is your great example as scientists? And please give a motivation why.
I actually use everyone as great examples, and as scientists, I learned a lot from my supervisors and colleagues. However, I am greatly motivated by Dr. Angelle Desiree LaBeaud because she’s one of the myth-breakers of motherhood in science. This year, she received a Woman in Science Award given by International Society of Antiviral Research for her contribution in investigating the epidemiology of arboviral infection, in particular her dedication in arbovirus research in Kenya. From her experience, I can learn that there is a possibility to have an elevating career in science without having to choose between family and work.
Which research discovery that you have made has made you most proud?
I’m currently working on the discovery of novel antiviral drugs for dengue virus, one of the most pathogenic mosquito-borne virus. One discovery that I contributed to (of which i’m very proud of) is identification of the target from one of our antiviral drug candidates, posaconazole. Moreover, the host target that we identified was never been reported to be involved in dengue virus replication mechanism before. Therefore, besides identified the target of posaconazole for its inhibition activity against dengue virus, we also found a potential host target that can be a candidate for further antiviral drug development.
Given unlimited finance what experiment would you perform?
Of course, clinical trials of the dengue antiviral drug candidates that have been successfully characterized. Besides that, I’d like to build a research center focusing on antiviral drug screening and characterization on natural sources in Indonesia.
What does your working area (desk, office) look like and what does it say about you (or your research)?
It’s intermediate, I’d say. Not so tidy yet not so messy. I’m not entirely sure what it says about my research, though. However, if you happen to see my desk super clean, that means I’m either on holiday or in a serious stress.
Nominate a colleague to be in the spotlight and what would you like to ask him or her?
Bodine Bezemer. If you only have two options to survive in this world: listening to the whole album of Kensington every single day or make 100 types of replicon ….. stable cell lines, which one will you choose?
What type of person are you, quick insights:a) Mac or PC? : Mac
b) Theater or cinema? : Cinema
c) Dine out or dine in? : Dine in
d) Ferrari or Fiat? : Neither
e) Shopaholic or chocoholic? : Shop-a-choco-holic
f) Culture or Nature : Nature
Related news items
Radboud-led collaboration generates innovative candidate drug against malaria19 September 2019
A molecule once designed to cure the skin disease psoriasis appears to be particularly effective against malaria. The antimalarial properties were revealed thanks to one researcher’s inspired hunch when the psoriasis drug discovery programme came to a dead end.read more
Radboud university medical center opens first healthcare AI labs19 September 2019
These are the first two ‘labs’ in the east of the Netherlands that are part of the national Innovation Center for Artificial Intelligence and the first health labs. With these two initiatives, Radboudumc and its partners are investing heavily in the application of AI to health care.read more
A personal touch of Kartika Hapsari18 September 2019
In order to promote interaction amongst colleagues within RIMLS, we have a ‘personal touch’ series setting employees in the spotlight. A light-hearted manner to learn about the colleagues you know and those you don’t. This week: Kartika Hapsari.read more
Radboud study on Dirty Money wins Ig Nobel Prize17 September 2019
By shaking hands we are exchanging bacteria. Does this happen without direct hand-to-hand contact, for example when paying with paper money? Andreas Voss, clinical microbiologist at Radboudumc and CWZ, and colleagues in the United States received an Ig Nobel Prize for research into dirty money.read more
MMD Lecturer of the year award for Alessandra Cambi16 September 2019
At their annual MMD symposium, Alessandra Cambi, theme Nanomedicine, was chosen as lecturer of the year 2018-2019 of the Top Master "Molecular mechanisms of disease".read more